- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05568251
TDCS Combined With CT In Opioid Use Disorder (OpiStim)
October 4, 2022 updated by: Serkan Aksu, Istanbul University
Transcranial Direct Current Stimulation Combined With Cognitive Training In Opioid Use Disorder
The aim of the present study is to investigate the effect of prefrontal transcranial Direct Current Stimulation (tDCS) combined with cognitive training on cognitive functions in individuals with Opioid Use Disorder (OUD).
The participants will be allocated into active/sham groups (1:1) and will receive a single session of prefrontal tDCS combined with cognitive training.
Outcomes of the active and sham groups will be compared.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul University
-
Istanbul, Turkey
- Research, Treatment and Training Center for Alcohol and Substance Dependence (AMATEM)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 61 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being aged between 18-65 years
- being in the maintenance phase of the OUD treatment
- naivety to tDCS
- at least 5 years of education
Exclusion Criteria:
- current diagnosis of major depressive disorder
- current diagnosis or history of bipolar disorders, psychotic disorders, neurocognitive disorders, pervasive developmental disorders, mental retardation, severe neurological disorders,
- common tDCS contraindications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active tDCS combined with Cognitive Training
|
Participants will receive a single session of active/sham tDCS.
During each session, 2 milliAmpers of active or sham tDCS will be applied for 20 minutes over the dorsolateral prefrontal cortex (right anodal/left cathodal).
Participants will be administered Game of Dice Task concurrent with the tDCS session
|
|
Sham Comparator: Sham tDCS combined with Cognitive Training
|
Participants will receive a single session of active/sham tDCS.
During each session, 2 milliAmpers of active or sham tDCS will be applied for 20 minutes over the dorsolateral prefrontal cortex (right anodal/left cathodal).
Participants will be administered Game of Dice Task concurrent with the tDCS session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the Iowa Gambling Task net score
Time Frame: Before and immediately after the intervention
|
Iowa Gambling Task net score is the total score of the task (between -100 and 100) that generally assesses the decision making under ambiguity, but also assesses the decision making under risk at the later stages.
Higher scores in the task represents better decision making and healthy people generally have scores above 8-10 in the task.
|
Before and immediately after the intervention
|
|
Changes in the Adjusted Number of Pumps in the Balloon Analogue Risk Task
Time Frame: Before and immediately after the intervention
|
The Balloon Analogue Risk Task is the commonly used computerized measure of decision making under risk.
Main outcome variable of the task is the Adjusted Number of Pumps which includes the mean number of pumps in the trials that not resulted with an explosion.
Lower values mean lower impulsivity.
|
Before and immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Interference Time in the Stroop Test
Time Frame: Before and immediately after the intervention
|
The stroop effect (Interference Time) consists of both the semantic and the response conflict.
Response conflict (time in milliseconds) is obtained by subtracting the semantic conflict (time in milliseconds obtained in the second step of the protocol) from the stroop effect (time in milliseconds obtained in the first step of the protocol).
Minimum time difference is 0 and maximum time difference is 100 milliseconds.
Lower time differences indicate better performance and higher time differences indicate worse performance.
|
Before and immediately after the intervention
|
|
Changes in the Stop Signal Reaction time in the Stop Signal Test
Time Frame: Before and immediately after the intervention
|
The Stop-Signal Task (SST) is a task requiring inhibition of a prepotent motor response.
The SST requires participants to respond to a target stimulus as quickly and accurately as possible by pressing a button, but also to withhold their response when they hear an auditory signal.
Thus, this task involves a competition between activating and inhibiting processes.
The primary outcome variable is change in the stop signal reaction time (SSRT) for the task administered seconds to minutes before and seconds to minutes after stimulation.
The theoretical minimum is zero seconds and there is no theoretical maximum.
Higher SSRT scores reflect greater impulsivity.
|
Before and immediately after the intervention
|
|
Changes in the verbal fluency performance
Time Frame: Before and immediately after the intervention
|
Verbal fluency is a test that measure multiple domains of cognition such as executive functions and language functions.
Phonemic Fluency assesses the number of words beginning with certain letters that participants can generate within 60 seconds, the semantic Fluency assesses the number of words within particular categories participants can generate within 60 seconds.
Alternating fluency assesses the number of fruit-name pairs reported in a minute duration.
Theoretical minimum is zero and there is no theoretical maximum .
Lower scores indicate worse performance and higher scores indicate better performance.
|
Before and immediately after the intervention
|
|
Changes in the digit span performance
Time Frame: Before and immediately after the intervention
|
The Digit Span test is a measure of verbal short-term/working memory. Subjects must recall all digits either in forward (digit span forward) or backward (digit span backward) order. Digit span forward total score: 0-10; higher score indicate better performance, digit span backwards total score: 0-10; higher score indicate better performance |
Before and immediately after the intervention
|
|
Changes in the Trail Making Test A Time
Time Frame: Before and immediately after the intervention
|
Trail Making A Test is a widely used as a quick and easy to administer measure of attention.
Lower reaction times indicate better performance and higher reaction times indicate worse performance.
Minimum time is 10 milliseconds and maximum time is 150 milliseconds.
|
Before and immediately after the intervention
|
|
Changes in the Trail Making Test B Time
Time Frame: Before and immediately after the intervention
|
Trail Making B Test is a widely used as a quick and easy to administer measure of executive functions.
Lower reaction times indicate better performance and higher reaction times indicate worse performance.
Minimum time is 10 milliseconds and maximum time is 150 milliseconds.
|
Before and immediately after the intervention
|
|
Changes in the Letter Number Sequencing (LNS) Test performance
Time Frame: Before and immediately after the intervention
|
Letter number is a test of working memory which involves ordering a series of up to 8 letters and numbers in which the numbers are repeated back first in order starting with the lowest number, then followed by the letters in alphabetical order.
LNS consists of 10 items and each item has 3 trials rated as Incorrect (0) or Correct (1).
The LNS total raw score (range 0 to 30) is auto-calculated by summing the 10 individual item scores (range 0 to 3 for each item).
Higher number of correct items correlated to better performance and a negative change from baseline indicates worsening.
|
Before and immediately after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Serkan Aksu, Istanbul University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
June 1, 2020
Study Completion (Actual)
June 1, 2020
Study Registration Dates
First Submitted
October 1, 2022
First Submitted That Met QC Criteria
October 1, 2022
First Posted (Actual)
October 5, 2022
Study Record Updates
Last Update Posted (Actual)
October 6, 2022
Last Update Submitted That Met QC Criteria
October 4, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-438
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.